Pracinostat and Gemtuzumab Ozogamicin (PraGO) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Clinical trial NCT03848754 · COMPLETED

Trial details

NCT number: NCT03848754
Sponsor: Medical College of Wisconsin
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed Adult AML

Start date: 2019-05-24
Primary completion: 2021-05-05
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.